Němec P.:
Significant Developments Occurred in Surgical Myocardial Revascularisati-on
During Last Decade
|
464 |
Vavřinec J., Cinek O., Šumník Z., Koloušková S.1 , Malcová H., Drřvínek P., Šnajderová M.:
Prediction of Diabetes Mellitus ype 1 in Czech First-Degree Relatives of Diabetic Patients
|
483 |
Perušičová J.1 , Bárová H.2 , Hill M.2 ,†MašekZ.2:
C-peptide as the Decisive Factor for Classifi-cation
of Diabetes Mellitus ype 1 and Diabetes Mellitus ype 2
|
490 |
Svacina Š., Owen K.:
Obesity, Diabetes Type 2 and their Quantitative Relations
|
500 |
Šmahelová A., Zadák Z.:
Nutritional Support of Diabetics with Acute Diseases during
Old Age from the Aspect of the Diabetologist
|
507 |
Rybka J.1 , Kvapil M.2:
New Oral Antidiabetics and Contemporary Strategy of AD Therapy
|
517 |
Pelikánová T.:
Contemporary Trends of Insulin Therapy
|
523 |
Bartoš V.:
Atherosclerosis, Alcohol, and Diabetes
|
529 |
Lacigov S., Rušavý Z., Čechurov D., Jankovec Z., Žourek M.:
Autonomic Neuropathy
in Diabetic atients, Therapeutic ossibilities
|
534 |
Jirkovsk A.:
The Fundamental Questions in the Therapy of Diabetic Foot Syndrome
|
542 |
Jirásek V.:
Examination in Familial Adenomatous olyposis
|
552 |
Ehrmann J.:
Etiopathogenesis of iarrhoea and Basic iagnostic and Therapeutic
Principles
|
563 |
Černoch J.:
New Indications of Transcutaneous Cholangioscopy
|
575 |
Lata J.1 , Hůlek P.2 , Fejfar T.2 , Špičák J.3 , Drastich P.3 , Mareček Z.4 , Brůha R.4 ,Husová L.1 , Šenkyřík M.1:
Rifaximine in the Treatment of Hepatic Encephalopathy
|
578 |
Zbořil V.:
Anticytokine in the Treatment of Idiopathic Inflammation of the Gut -Theory
and Practice
|
583 |
Dolina J., Hep A., Díte P., Münzová H., Kunov ká M., Husová L., Plottová Z.:
Barrett´s
Oesophagus
|
587 |
